Your session is about to expire
← Back to Search
Tranexamic Acid for Postoperative Complications
Study Summary
This trial will evaluate whether injecting tranexamic acid (TXA) before Mohs surgery can help reduce bleeding and pain during surgery, and lead to fewer post-operative complications.
- Skin Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 1226 Patients • NCT04733157Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are pregnant.You are currently taking medication called systemic retinoids.You are allergic to TXA.You have had a blood clot in a deep vein or in your lungs before.
- Group 1: Tranexamic acid
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must be met for prospective participants to qualify for this research?
"In order to be considered for inclusion in this medical trial, individuals must possess a diagnosis of skin cancer and be within the ages of 18 - 99. 200 participants are desired overall."
Is this experiment currently accepting participants?
"Evident from the clinicaltrials.gov website, this trial is not presently recruiting participants. Initially posted on June 16th 2021, it was last updated April 6th 2022; however, there are 478 other studies currently accepting applicants."
Are there any peer-reviewed reports that analyze the effectiveness of Tranexamic acid injection?
"Currently, 199 Tranexamic acid injection studies are in progress; 62 have reached Phase 3. While the bulk of these trials is based at one location in Duarte, California, 1319 sites throughout the world are examining this treatment's efficacy."
To what medical ailments is Tranexamic acid injection commonly administered?
"Tranexamic acid injection is commonly administered for idiopathic anaphylaxis, though it has other uses such as reducing skin irritation and controlling uterine contractions or laryngotracheobronchitis."
What is the total number of participants being enrolled in this investigation?
"Recruitment for this trial is no longer available. It was first posted June 16th 2021 and edited most recently on April 6th 2022. Alternatively, those interested in participating may consider the 279 clinical trials seeking participants with skin cancer or the 199 investigating tranexamic acid injections."
Is the age qualification for this clinical research limited to those under 30?
"This medical study is actively enlisting individuals who are of legal age and not yet a centenarian."
Share this study with friends
Copy Link
Messenger